Bekele Delayehu, Asfaw Mariamawit, Nigatu Balkachew, Kebede Birhanu, Tolu Lemi Belay, Abdosh Abdulfetah Abdulkadir, Sium Abraham Fessehaye
Department of Obstetrics and Gynecology, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
AJOG Glob Rep. 2023 Aug 1;3(3):100252. doi: 10.1016/j.xagr.2023.100252. eCollection 2023 Aug.
Although recent evidence suggests the simultaneous approach use of oxytocin for induction of labor in nullipara, there is limited data from low-income settings that support this.
This study aimed to determine whether induction of labor with simultaneous use of oxytocin and a Foley balloon catheter decreases the induction of labor to delivery interval in nulliparous women, compared with sequential use of a Foley balloon catheter followed by oxytocin.
This was a randomized controlled trial of nulliparous women with singleton pregnancies presenting for induction of labor at >28 weeks of gestation at St. Paul's Hospital Millennium Medical College (Addis Ababa, Ethiopia). The participants were randomly assigned to either the simultaneous group (the use of oxytocin and a Foley balloon catheter for induction of labor) or the sequential group (overnight intracervical Foley balloon catheter placement followed by the use of oxytocin the next morning). The primary outcome was induction of labor to delivery interval. Comparisons between the groups were made using the Student test or Wilcoxon rank-sum test and chi-square test on Stata (version 15; StataCorp LLC, College Station, TX). This study is registered with the Pan African Clinical Trials Registry (identifier: PACTR201709002509200).
From November 2019 to March 2020, a total of 140 women were randomly assigned to the simultaneous group (70 women) or the sequential group (70 women). The median oxytocin initiation to delivery intervals were 6.09 hours (range, 4.03-10.7) in the sequential group and 8.1 hours (range, 4.7-11.6) in the simultaneous group (=.46). The mean Foley balloon catheter insertion to delivery intervals were 16.09±5.7 hours in the sequential group and 8.06±4.2 hours in the simultaneous group (<.001). Cesarean delivery rate, composite neonatal outcomes, and chorioamnionitis were not different between the 2 groups.
In nulliparous pregnant women, induction of labor using the simultaneous approach did not shorten the oxytocin initiation to delivery interval compared with the sequential approach. Moreover, both approaches showed no difference in the rates of adverse maternal and neonatal outcomes.
尽管最近的证据表明初产妇引产时可同时使用缩宫素,但来自低收入地区支持这一做法的数据有限。
本研究旨在确定与先使用弗利导尿管再使用缩宫素的序贯方法相比,同时使用缩宫素和弗利导尿管进行引产是否能缩短初产妇引产至分娩的间隔时间。
这是一项针对在圣保罗医院千禧医学院(埃塞俄比亚亚的斯亚贝巴)妊娠>28周前来引产的单胎初产妇的随机对照试验。参与者被随机分配到同时组(使用缩宫素和弗利导尿管引产)或序贯组(夜间宫颈内放置弗利导尿管,次日早晨使用缩宫素)。主要结局是引产至分娩的间隔时间。使用Stata(版本15;StataCorp有限责任公司,德克萨斯州大学城)软件中的Student检验或Wilcoxon秩和检验以及卡方检验对两组进行比较。本研究已在泛非临床试验注册中心注册(标识符:PACTR201709002509200)。
2019年11月至2020年3月,共有140名女性被随机分配到同时组(70名女性)或序贯组(70名女性)。序贯组缩宫素开始使用至分娩的间隔时间中位数为6.09小时(范围4.03 - 10.7小时),同时组为8.1小时(范围4.7 - 11.6小时)(P = 0.46)。序贯组弗利导尿管插入至分娩的平均间隔时间为16.09±5.7小时,同时组为8.06±4.2小时(P<0.001)。两组的剖宫产率、综合新生儿结局和绒毛膜羊膜炎无差异。
在初产妇中,与序贯方法相比,同时使用缩宫素引产并未缩短缩宫素开始使用至分娩的间隔时间。此外,两种方法在孕产妇和新生儿不良结局发生率方面无差异。